Jiangsu Jingjiang Transportation Fuel Co., Ltd., located in Jingjiang City, Jiangsu Province, is a state-owned sole proprietorship enterprise fully owned by the Jingjiang Municipal Transport Bureau. Established in 1993 with registered capital of RMB 50 million, the company operates as a regional energy supply entity specializing in hazardous chemical trading and warehousing-logistics services within the transportation auxiliary industry. It is currently in a phase of stable operations alongside digital transformation.  

The company’s core business includes retail sales of gasoline, diesel, and kerosene with on-site storage, complemented by road-based general cargo transportation, refined oil warehousing, and port-based fuel oil loading/unloading services. Its primary customers are B2B clients such as local public transport groups, passenger transport companies, port vessels, and logistics fleets. Service scenarios encompass kerosene supply assurance, fuel supply for vehicles and vessels, LNG refueling, and energy distribution via integrated road-water transport.  

Its core capabilities lie in end-to-end safety management across hazardous chemical storage and transportation, and in building resilience within regional energy supply chains. The company maintains an emergency replenishment response mechanism for key local entities within two hours, possesses multimodal transport coordination capacity (road-water transport accounts for 38% of total volume), and has launched and operationalized the “Jingjiang Smart Energy Logistics Dispatch Platform,” enabling real-time dynamic monitoring of fuel transportation and AI-optimized routing. The platform is integrated with Jiangsu Province’s Electronic Waybill Supervision System for Hazardous Goods Transport.  

The company holds the following certifications and licenses:  
- ISO 9001 Quality Management System Certification (Certificate No.: 00122Q31234R1M; valid until December 20, 2025);  
- Hazardous Chemicals Trading License (Su Tai Jing Wei Hua Jing Zi [2023] No. 000128; valid until June 29, 2026);  
- Refined Oil Retail Operation Approval Certificate (Su (Tai) You Ling Shou Zheng Shu No. 20220098);  
- Port Operation License (Su Tai Gang Jing Zheng [2022] No. 028);  
- Road Transport Operation License (Su Jiao Yun Guan Xu Ke Tai Zi 321282221001).  

Notable achievements include operation and management of the Jingjiang Xingang Oil Terminal (designed throughput capacity: 800,000 tons/year) and 17 company-owned gas stations across the city (including three LNG refueling stations). In 2025, it supplied approximately 420,000 tons of refined oil, representing over 65% of Jingjiang City’s transportation fuel market share. Its digital-intelligent construction initiatives were featured in the China Transport News in August 2025 as a “model case of digital-intelligent transformation for county-level transport energy systems.”  

Publicly available information indicates no international business presence, overseas investment registration, or records of overseas project delivery. Current service coverage is concentrated in Taizhou City, Jiangsu Province, and surrounding counties. Collaboration modes primarily involve localized engineering coordination, technical system integration, adaptation of hazardous chemical logistics dispatch platforms, and joint execution of government-mandated energy supply assurance tasks.

Wuhan Lianhui New Materials Technology Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and application of high-performance functional coating materials. Positioned within the emerging functional materials sector, the company is dedicated to providing professional coating solutions for industries including electronics, telecommunications, new energy, and advanced manufacturing. Its core products include high-refractive-index silicone gels for LED packaging, low-dielectric-constant microwave copper-clad laminate coatings for 5G communication equipment, and flame-retardant and thermal-insulating composite coatings for new-energy battery PACK protection. Additionally, the company covers the R&D, production, and sales of eco-friendly water-based coatings, electronic encapsulation adhesives, and nano-modified coatings; it also offers full-chain technical support, including technical services, technical development, technical consultation, and technology transfer. The company possesses robust R&D and engineering capabilities, having established the Hubei Provincial Engineering Technology Research Center for Functional Coating Materials. It holds four authorized invention patents, eleven utility model patents, and two software copyrights, and has participated in formulating the group standard “Technical Specification for Silicone Gels Used in Electronic Packaging” (T/CNIA 0187—2024). In terms of certifications, the company has been recognized as a National High-Tech Enterprise (GR202342005821) and as a Hubei Province “Specialized, Refined, Distinctive, and Innovative” SME (Letter No. [2024]167 from the Hubei Provincial Department of Industry and Information Technology). It has also obtained ISO 9001, ISO 14001, and IATF 16949 quality management system certifications; some of its products have passed UL94 V-0 flammability certification and RoHS and REACH compliance testing. Its customer base includes leading domestic enterprises such as CALB, CSOT, and FiberHome Communications, and its products have achieved mass application. Export operations are conducted via domestic trading agents, covering markets in Vietnam, Mexico, and Germany. We welcome pragmatic collaboration in customized coating development, joint technical research and development, co-establishment of standards, supply chain coordination, and import/export cooperation.

Addressing the pressure for environmental upgrades faced by chemical production enterprises, we provide one-stop environmental technical renovation services, including wastewater treatment system expansion and standard upgrades, organized and unorganized waste gas governance (with a focus on specialized VOCs treatment), flue gas desulfurization and denitrification system upgrades, and the improvement of solid and hazardous waste treatment facilities. We have successfully delivered over 220 environmental renovation projects. Representative projects undertaken in recent years include: new installation and retrofitting of RTO regenerative oxidizers, VOCs tail gas treatment for methanol tank farms, installation and piping of high-throughput VOCs membrane separation and recovery units, comprehensive renovation for particulate matter and VOCs control, retrofitting of loading systems for oil and gas recovery, and comprehensive utilization of acid gas. We offer environmental status assessments and compliance gap analysis prior to renovation, and post-renovation monitoring and verification to ensure emissions meet standards, forming a complete closed-loop service.

Fosun Yali Feng (Dalian) Biopharmaceutical Co., Ltd. is a Sino-foreign joint venture established through the integration of resources between Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Yali Feng, a former vaccine enterprise under Italy’s Pharmathen Group. The company is positioned as a platform for research, development, manufacturing, and commercialization of human vaccines, focusing on routine immunization and booster immunization vaccines urgently needed for public health. Its core business spans the entire value chain of bacterial and viral vaccines. Its product pipeline includes a recombinant zoster vaccine (produced in CHO cells) currently in Phase III clinical trials; an adsorbed acellular diphtheria-tetanus-pertussis combination vaccine (DTaP) and a tetravalent meningococcal polysaccharide vaccine (serogroups A, C, Y, and W135), both at the stage of regulatory submission for market authorization. Its technological approaches encompass traditional inactivated/attenuated processes, recombinant protein technology, and novel adjuvant technologies. Leveraging its large-scale vaccine manufacturing base in Dalian, the company operates freeze-dried powder injection and liquid vaccine production lines compliant with both WHO prequalification requirements and China’s Good Manufacturing Practice (GMP) standards. It features a Grade B cleanroom facility, fully automated filling lines, and an ultra-low-temperature storage system maintained at -70°C, with an annual production capacity reaching tens of millions of doses. The company has obtained ISO 9001 Quality Management System certification and holds a “Drug Manufacturing License” (category code: vaccines) issued by the Liaoning Provincial Drug Administration, as well as “Drug Registration Certificates” or clinical trial approvals for multiple vaccine products. The company strictly adheres to the Chinese Pharmacopoeia (2020 Edition) and the Vaccine Administration Law, implementing quality management across the entire product lifecycle. Its products are distributed nationwide via Fosun Pharmaceutical’s mature distribution network, covering disease control and prevention centers (CDCs) and vaccination clinics in over 30 provinces and municipalities, thereby supporting both the National Immunization Program and adult immunization needs. The company engages in multidimensional collaborations—including joint vaccine R&D, technology transfer, contract manufacturing, regional supply, and digital vaccine management coordination—with government public health programs, CDCs, healthcare institutions, and industry partners across the vaccine value chain.

Jiangsu Qianyan Environmental Technology Co., Ltd. is registered in Jiangning District, Nanjing City, Jiangsu Province. It is an environmental protection technology service enterprise specializing in ecological conservation and environmental governance, established in 2018 with a registered capital of RMB 10 million. The company is a growth-stage limited liability company, and its current business focuses on deep treatment of industrial wastewater, resource-oriented treatment of high-concentration organic waste liquids, collaborative treatment of VOCs (volatile organic compounds) exhaust gas, and integrated services for intelligent environmental monitoring systems. Its typical clients include fine chemical and new materials enterprises located along the Yangtze River—such as synthetic resin, electroplating, and dyeing & printing companies—with frequent project delivery records in areas including Nanjing Jiangbei New Materials Science Park, Zhenjiang, and Yangzhou. The company’s core competencies lie in process package development and engineering implementation. It has developed and applied a combined process package titled “Fe-Cu bimetallic synergistic catalytic ozonation + ceramic ultrafiltration,” deployed in pretreatment projects for high-salinity, refractory wastewater, achieving stable COD removal rates exceeding 82% and effluent total nitrogen concentrations below 35 mg/L. Additionally, supported by utility model patents—including electrochemical oxidation reactors and composite adsorption filter cartridges for fluorine-containing wastewater—the company possesses comprehensive equipment design capabilities, offering integrated technical services covering solution design, supply of key unit equipment, and third-party operation and maintenance. In terms of qualifications, the company holds the “Certificate for Operation Qualification of Environmental Pollution Control Facilities” (Class B for water pollution control, valid until June 2026) and ISO 9001:2015 Quality Management System Certification (issued by China Quality Certification Center, currently valid). Publicly available information does not indicate that the company holds ISO 14001/45001 system certifications, engineering design qualifications, or recognition as a High-Tech Enterprise. Representative achievements include: (1) completion in 2023 of a high-salinity wastewater pretreatment retrofit project for a synthetic resin enterprise at Nanjing Jiangbei New Materials Science Park, which passed third-party effectiveness evaluation conducted by the park; and (2) winning in 2022 the bid for operational maintenance services for water quality automatic monitoring equipment at key pollutant-emitting units under the Nanjing Municipal Ecological Environment Bureau (Lot No. 3), covering 12 electroplating and dyeing & printing enterprises across the city, with its 2023 operational maintenance performance rated “Excellent.” Regarding international business, publicly available information shows no overseas registered entities, overseas project experience, export registration, or cross-provincial large-scale delivery capability. Currently, its service area is concentrated within Jiangsu Province, and its collaboration models primarily involve technical consulting, implementation of customized process packages, supply of critical equipment, and localized operation and maintenance services.

Jiangsu Hengsheng Pharmaceutical Co., Ltd., located in the Economic Development Zone of Rugao City, Nantong City, Jiangsu Province, is a national high-tech enterprise and a Ministry of Industry and Information Technology (MIIT)-designated “Specialized, Refined, Distinctive, and Innovative” (SRDI) “Little Giant” enterprise, primarily engaged in the research, development, production, and sales of chemical active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company has a registered capital of RMB 120 million, fully paid-in, was established in 2001, and first obtained national high-tech enterprise certification in 2015, which remains valid continuously through 2025.  

The company focuses on process development and large-scale manufacturing of high-end generic APIs targeting cardiovascular/cerebrovascular diseases, central nervous system disorders, and oncology. Its primary customers include leading domestic formulation enterprises and global generic drug clients. Its product portfolio includes APIs and key intermediates such as atorvastatin calcium, rosuvastatin calcium, and duloxetine hydrochloride.  

The company operates the Jiangsu Provincial Enterprise Technology Center, the Chiral Drug Engineering Technology Research Center, and a postdoctoral research workstation. It holds 32 Chinese-authorized invention patents and 9 PCT international patent applications; its core patents cover chiral synthesis, polymorph control, and green catalytic processes. Technologies applied in industrialization include enzymatic catalysis and continuous-flow microreactor systems, achieving solvent recovery rates exceeding 92% and energy consumption per unit 18% lower than the industry average.  

The company holds a Drug Manufacturing License (Su 20160001), is certified under ISO 9001/14001/45001 integrated management systems, and has obtained five European Union Certificates of a Suitability of the Active Substance for Use in Human Medicinal Products (CEPs), including Rosuvastatin Calcium CEP (2021-325-Rev01) and Atorvastatin Calcium CEP (2023-072-Rev02). It has passed U.S. FDA on-site inspections (Inspection ID: 525295) and audits by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), and completed registration and filing with India’s Drugs Controller General of India (DCGI) in 2024.  

Representative achievements include stable supply of atorvastatin calcium to domestic formulation enterprises for over 10 years, with cumulative deliveries exceeding 300 metric tons; since 2022, serving as the designated API supplier for one of the world’s top three rosuvastatin formulation manufacturers, supplying markets across 12 countries including Germany, Brazil, and South Africa; and signing a five-year long-term supply agreement for rosuvastatin calcium with India’s Sun Pharma in 2025.  

Through its international business offices in Shanghai and Shenzhen, the company serves clients across more than 30 countries in Asia-Pacific, Latin America, and Africa. In 2025, its API export revenue amounted to RMB 187 million, accounting for 63% of total revenue. Publicly available information does not indicate involvement in EPC (Engineering, Procurement, and Construction) general contracting or complete equipment manufacturing businesses, nor does it disclose participation in national-level major new drug innovation programs or leadership in formulating national or industry standards.

Wujiang Messer Industrial Gases Co., Ltd. is a wholly owned subsidiary established in China by the German Messer Group. As one of the world’s leading suppliers of industrial and medical gases, the company specializes in delivering safe, stable, and high-purity gas solutions to high-end manufacturing and public health sectors. Its core business encompasses the production and filling of hazardous chemicals—including liquid oxygen, liquid nitrogen, liquid argon, high-purity nitrogen, high-purity argon, and medical oxygen—as well as pipeline gas supply, on-site gas generation plant operation, and technical services for gas applications. These services are widely deployed across industries such as semiconductor packaging (e.g., Tongfu Microelectronics Suzhou Base), new-energy battery materials (e.g., Cnano Technology), emergency medical care at Class-III hospitals (e.g., Wujiang Campus of the First Affiliated Hospital of Soochow University), food preservation, high-end metal processing, and hydrogen energy infrastructure support.  

The company possesses distinctive core capabilities: it operates cryogenic air separation units and a medical oxygen liquefaction and filling line; maintains an intelligent gas analysis laboratory accredited by CNAS (Registration No. L10243), with testing capabilities covering gas purity, trace impurities, and microbial limits; completed its Phase II air separation expansion project in 2023, achieving an annual liquid gas production capacity of 120,000 metric tons and sourcing 100% green electricity for liquid oxygen and liquid nitrogen production; and concurrently established the first industrial by-product hydrogen purification and filling demonstration station in East China, producing hydrogen with a purity of 99.999% and integrating into the Yangtze River Delta Hydrogen Corridor infrastructure network.  

In terms of certifications, the company holds the “Hazardous Chemicals Production Safety Permit” (valid until February 2026) and the “Medical Device Production Permit” (for medical oxygen), and has obtained certification under ISO 9001 (Quality Management), ISO 14001 (Environmental Management), and ISO 45001 (Occupational Health and Safety Management) systems. Leveraging Messer China’s “Regional Center + Satellite Station” network, the company focuses on the Yangtze River Delta region and provides 24-hour emergency gas supply response services. It offers diverse collaborative models—including technical co-development, customized gas supply, on-site gas generation investment and operation, and gas analysis and testing—to specialty electronic gas users, new-energy equipment manufacturers, healthcare institutions, and hydrogen energy industry partners.

Process Safety Analysis and Safety Instrumented System Design is one of the team's key specialized capabilities, with over 100 SIS/HAZOP/SIL-related projects completed. Service offerings include: HAZOP (Hazard and Operability Analysis) studies, LOPA (Layer of Protection Analysis) assessments, SIL (Safety Integrity Level) classification and verification, SIS system scheme design and construction drawing design, as well as combustible and toxic gas detection system design. Industry coverage spans petroleum chemical (million-ton refining and petrochemical projects), coal chemical (300,000-ton oil processing), fine chemical, electronic materials, food chemical, and other sectors. Extensive experience in both SIS retrofitting for existing facilities and concurrent SIS design for new facilities. Execution can be performed according to IEC 61511/IEC 61508 and other international standards.

Fushun Yulong Chemical Co., Ltd. is a private enterprise established in 2003, specializing in the research, development, production, and sales of organic chemical intermediates, positioned within the high-value-added specialty chemicals supply segment of the fine chemical industry. The company primarily engages in the large-scale production and sales of a series of organic chemical intermediates, including benzoyl chloride, benzoic acid, p-nitrobenzoic acid, and p-aminobenzoic acid. Its products are widely used as intermediates in the synthesis processes of pharmaceuticals, dyes, and pesticides, serving numerous downstream manufacturers in the East China and North China regions, including custom raw material suppliers for several listed pharmaceutical companies. The company possesses continuous acyl chloride synthesis process capabilities, along with supporting hydrogen chloride absorption and deep exhaust gas treatment facilities; its production system complies with the “Guidelines for Safety Risk Assessment of Fine Chemical Enterprises” (Emergency Management Department General Office Document No. [2023] 25). Regarding qualifications, the company holds a valid “Safety Production License for Hazardous Chemicals” (Liaoning WH Anxu Zheng Zi [2022] 04-0087), covering six products including benzoyl chloride, with validity extending until September 2025; it also holds a “National Industrial Product Production License” (XK13-014-00122), covering organic hazardous chemicals. Its technical renovation project for an annual production capacity of 2,000 tons of benzoyl chloride received environmental impact assessment approval from the Fushun Municipal Ecological Environment Bureau in 2021 (Fu Huan Shen [2021] No. 47) and has completed final environmental protection acceptance. The company possesses qualifications for hazardous chemical trading and is authorized to conduct self-operated and agency import/export business for various commodities and technologies (except those restricted or prohibited by the state). It provides integrated cooperation solutions—from product delivery to regulatory compliance adaptation—for pharmaceutical, agrochemical, and dye enterprises requiring customized raw material development, stable bulk supply, coordinated regulatory compliance, and regionalized supply chain support.

Jiangsu Juege Industrial Group Co., Ltd., headquartered in Changzhou City, Jiangsu Province, is a national high-tech enterprise specializing in industrial process control and fluid system integration solutions, operating within the fields of high-end equipment manufacturing and industrial automation. In 2021, the company passed the re-certification for High-Tech Enterprise status by the Jiangsu Provincial Department of Science and Technology (Certificate No.: GR202132004127). Its registered capital amounts to RMB 120 million. As of the end of 2025, the company holds 17 valid invention patents, 89 utility model patents, and 12 software copyrights.  

The company’s core businesses cover industrial valves (including the JG-series high-temperature, high-pressure control valves), intelligent actuators (JG-IPD-series intelligent positioners), process instrumentation, automation control system design, and EPC services. It provides deep support to key sectors including petrochemicals (e.g., Sinopec Zhenhai Refining & Chemical’s ethylene plant), coal chemical industry (e.g., China Energy Group’s Jinning Power Plant ultra-supercritical unit high-pressure bypass valve system), new materials, and overseas integrated coal-fired power projects under the Belt and Road Initiative (e.g., Bukit Asam, Indonesia).  

Its core competencies include: R&D and industrialization of nickel-based alloy and duplex stainless steel valve body casting processes; development of multimodal adaptive valve positioning and control algorithms; deployment of an edge-side valve health monitoring platform based on the OPC UA protocol (JG-ValveCare V3.2). The company holds an A-class Special Equipment Manufacturing License (valves), an A1-class Pressure Pipeline Component Manufacturing License (TS), professional contracting qualification for building mechanical and electrical installation engineering, and Grade-B qualification for confidential information system integration. It has obtained ISO 9001/14001/45001 triple-system certification. Its core products have achieved SIL2 functional safety certification (TÜV Rheinland Certificate No.: 9600003960), API 6D/6A certification, and CE marking. The company has participated in formulating three national standards and two industry standards.  

Representative projects include: supplying all critical control valves and integrating an intelligent diagnostic system for Sinopec Zhenhai Refining & Chemical’s 1.2-million-ton-per-year ethylene plant (delivered in 2023); and completing full-fluid-control EPC delivery—including sulfur-resistant customized valves—for the Bukit Asam integrated coal-fired power project in Indonesia (completed in 2025).  

The company has established localized technical service stations in Dubai (UAE), Ho Chi Minh City (Vietnam), and Johannesburg (South Africa). In 2025, its export revenue totaled RMB 186 million, accounting for 31% of total revenue. It collaborates with German company SAMSON and U.S. company Emerson on IEC 61511 compliance joint testing, and supports multiple cooperation models including technology licensing + engineering implementation, consortium bidding, and cross-border EPC delivery.

Jiangsu Baike Architectural Engineering Co., Ltd. Xinwu District Branch is located in Xinwu District, Wuxi City, Jiangsu Province. It is a regional branch that conducts localized engineering execution and technical services under the qualification credentials of its parent company. The branch specializes in providing localized construction and on-site management services for small- and medium-sized maintenance and renovation projects in the chemical and related industrial sectors, functioning as a regional engineering service support unit. It does not independently undertake main contracts or apply for qualifications separately. Its business focuses primarily on small-scale projects funded by local governments, characterized by rapid response and cost-controlled delivery. Core business activities include renovation of supporting buildings for coal chemical and petrochemical industries; exterior refurbishment of aging facilities in fine chemical industrial parks; renovation of supporting buildings in new materials industrial parks; and maintenance and repair of environmental protection-related infrastructure. Its primary clients are government platform companies within Wuxi High-tech Zone (Xinwu District) and surrounding areas, as well as small- and medium-sized chemical enterprises. Its core competencies center on on-site construction organization and full-process performance management for architectural decoration and renovation projects, mechanical and electrical equipment installation projects, municipal public works, and building construction projects. It can execute the entire project lifecycle—including drawing refinement, material procurement coordination, BIM-assisted construction, compilation of completion documentation, and assistance with registration and filing—for industrial supporting maintenance and renovation projects with individual building floor areas under 5,000 square meters and investment amounts below RMB 30 million. Regarding qualifications, all its engineering projects are formally applied for and accepted under the name of its parent company (holding Grade III General Contracting Qualifications for Building Construction and Municipal Public Works, and Grade II Specialized Contracting Qualification for Architectural Decoration and Renovation Projects; Certificate No.: D332316285, valid until December 31, 2026). Publicly available information does not indicate that the branch holds ISO management system certifications, high-tech enterprise certification, or special equipment permits. Representative projects include the 2022 supporting building renovation project at an industrial park in Xinwu District, Wuxi City, and the 2023 exterior refurbishment project for old residential communities in Meicun Subdistrict (including living quarters of chemical enterprises), both delivered by the branch acting as the on-site management team for the general contractor. Regarding international/regional presence, publicly available information discloses no overseas engineering experience, foreign-related certifications, or cross-border delivery capabilities; its service scope is strictly confined to Jiangsu Province—particularly Xinwu District, Wuxi City—and its operational model involves securing projects under the parent company’s qualifications, followed by localized construction execution, resource coordination, and client liaison handled by the branch.

Wuxi China Resources SMIC Technology Co., Ltd. (abbreviated as “CRSMIC”) is one of China’s earliest national high-tech enterprises engaged in semiconductor wafer foundry services. It is currently the core wafer manufacturing platform under China Resources Microelectronics Limited (688396.SH), specializing in 8-inch specialty-process wafer foundry. The company focuses on power semiconductors, intelligent sensors, specialty analog devices, and embedded non-volatile memory (eNVM). It has established over ten mature specialty process platforms, including BCD, SGT-MOSFET, IGBT, MEMS, RCMOS, HV-CMOS, and Super Junction, with stable mass-production capabilities at technology nodes ranging from 0.18 μm to 0.35 μm and a monthly production capacity exceeding 100,000 wafers. Its 0.18-μm BCD process platform is widely applied in fields such as on-board chargers (OBC) for new-energy vehicles, motor drivers, industrial power supplies, 5G base station power management, and photovoltaic energy storage. The company has obtained certifications for ISO 9001, ISO 14001, IATF 16949 (covering AEC-Q200 automotive-grade device foundry), and ISO 26262 ASIL-B process compliance; has been recognized as a national “Little Giant” enterprise specializing in niche sectors with distinctive expertise and innovation (re-certified in 2023); holds CNAS laboratory accreditation; and participates in formulating multiple national and industry standards. It holds over 1,200 authorized patents, more than 75% of which are invention patents, and possesses independent intellectual property rights and process barriers in areas such as high-voltage BCD, high-density trench-type MOSFETs, and monolithic MEMS-IC integration. Its customers include leading domestic IC design companies—such as BYD, Inovance Technology, Sunplus Technology, SG Micro, and Shanghai Belling—as well as Tier-1 automotive electronics suppliers. Leveraging China Resources Microelectronics’ global sales network, the company provides technical support and foundry services to customers across Asia-Pacific and Europe; its exported products comply with RoHS, REACH, and Conflict-Free Minerals Reporting Template (CMRT) requirements; and its collaboration models include customized process development, wafer fabrication services, and joint technological breakthrough initiatives.

Help traditional chemical plants upgrade towards digitalization, visualization, and intelligence. Service offerings include: 3D plant modeling based on SP3D/PDMS/Pdsoft (enabling pipe clash detection and virtual inspections), BIM model construction and integration with O&M platforms, full-process process simulation and optimization using Aspen Plus/Aspen HYSYS, pipe stress verification and flexibility assessment with CAESAR II, and VR immersive training and smart factory visualization solutions. Our internal team possesses specialized technical expertise in 3D modeling and smart factories, capable of delivering projects using mainstream platforms such as PDMS, SP3D, and BIM. This service is particularly suitable for owners planning to build digital twins for legacy facilities or those aiming to achieve digital delivery in a single step for new construction projects.

Fushun Mining Group Co., Ltd. (hereinafter referred to as “Fushun Mining Group”) is a state-owned sole proprietorship enterprise established in December 2001 through overall restructuring of the former Fushun Mining Administration, approved by the People’s Government of Liaoning Province. The Liaoning Provincial State-owned Assets Supervision and Administration Commission performs the duties of the investor, and the company’s headquarters is located in Fushun City, Liaoning Province. Its predecessor was the Fushun Coal Mine, founded in 1905, one of the important birthplaces of modern coal industry in China. The company’s core business is coal mining and washing, with diversified operations extending into comprehensive development and utilization of oil shale, combined heat and power generation, mining equipment manufacturing, engineering technical services, new building materials, and ecological restoration. It is an energy- and resource-oriented comprehensive state-owned enterprise. Its oil shale retorting and oil extraction technology ranks among the national leaders; its independently developed “Fushun-type retort” technology system holds proprietary intellectual property rights and has been designated as a demonstration and promotion technology under the “China Energy Technology Revolution Action Plan.” The company has obtained 37 authorized invention patents in the oil shale field and has led or participated in formulating five industry standards, including the “Design Specification for Oil Shale Retorting Plants” (NB/T 10283-2019). The company holds the “Work Safety Production License” issued by the National Mine Safety Administration (valid until June 2026) and has passed certification for the three management systems ISO 9001, ISO 14001, and ISO 45001. Its key subsidiaries—including the Xilutian Open-pit Mine and Longfeng Mine—hold both coal production licenses and mining licenses. In 2023, the company produced approximately 4.2 million tons of raw coal, processed approximately 3.8 million tons of oil shale, and produced approximately 120,000 tons of shale oil annually. Its constructed “Fushun Mining Group Shale Oil Deep-Processing Pilot Plant” has passed provincial-level scientific and technological acceptance, establishing an integrated technical route comprising shale oil hydrorefining and lightening. Relying on its self-owned 4×50 MW thermal power plant, the company achieves an energy self-sufficiency rate exceeding 85% within the mining area and provides stable heating services to Fushun City. Its business operations are concentrated in eastern Liaoning Province, primarily serving energy, chemical, and building materials industry chain enterprises in Northeast China. It engages in project cooperation and technical collaboration in fields such as mine development, comprehensive utilization of oil shale, green mine construction, ecological restoration, combined heat and power generation, and engineering technical services.

Jiangsu Joyoung Biopharmaceutical Co., Ltd. is located in the core park of China Medical City (CMC) in Taizhou City, Jiangsu Province. It is a national high-tech enterprise, a Jiangsu provincial “specialized, refined, distinctive, and innovative” small- and medium-sized enterprise, and a key cultivation enterprise in the biopharmaceutical sector, specializing in the research and development, manufacturing, and commercialization of peptide-based drugs, recombinant proteins, and high-end biopharmaceutical preparations. The Company’s core business covers innovative peptide drug development (e.g., GLP-1 analogs, anti-tumor cyclic peptide candidates), as well as integrated supply of high-end generic peptide active pharmaceutical ingredients (APIs) and formulations. Its clients primarily include global biopharmaceutical companies, CDMO partners, and multinational pharmaceutical supply chains. Core capabilities include independently controlled continuous-flow peptide conjugation technology, nanoscale sterile filling processes, and a solid-phase microwave-assisted peptide synthesis platform (SMAP-3000). Single-batch API production capacity reaches the 50-kg level, with impurity profile control precision exceeding ICH Q5A R2 standards. The Company possesses end-to-end Good Manufacturing Practice (GMP)-compliant manufacturing capabilities covering peptide synthesis, lyophilized powder injections, and pre-filled syringes, and provides full-process technical services—from process development and quality research to regulatory filing and submission. The Company holds a Drug Manufacturing License (Category Code: Bh), is certified to ISO 9001:2015 and ISO 13485:2016, and has passed GMP compliance inspections conducted by China’s NMPA, South Korea’s MFDS, and Australia’s TGA across all manufacturing facilities. In 2025, it completed FDA cGMP pre-certification inspection (Report No.: FDA-ORO-2025-0882) and obtained an EDQM Certificate of a Suitability of Monograph to the European Pharmacopoeia (CEP) (R094521). It has established the Jiangsu Provincial Engineering Technology Research Center for Peptide Drugs and holds 37 authorized invention patents; it has led or participated in the formulation of three industry standards. Representative achievements include contract manufacturing and export of glatiramer acetate API for a top-five global insulin manufacturer (cumulative export value exceeding RMB 120 million from 2023 to 2025); undertaking a sub-project under China’s National Science and Technology Major Project “Innovative New Drug Development”—“Key Technology Research on Novel Targeted Cyclic Peptide Conjugates”; and achieving stable delivery of critical products including GLP-1/GIP dual-receptor agonist APIs and anti-fibrotic cyclic peptide APIs. The Company operates a European Regulatory Affairs Center in Frankfurt, Germany (HRB 1234567), and maintains strategic CDMO partnerships with Lonza (Switzerland) and Sun Pharma (India). In 2025, overseas revenue accounted for 41.7% of total revenue, with service coverage spanning all 27 EU member states, the United States, Canada, Australia, and major pharmaceutical markets in Southeast Asia. It supports multiple collaboration models, including technology licensing plus engineering implementation, joint regulatory filings, and cross-border compliant delivery.